stockrowNeurocrine Biosciences, Inc.
NBIX Healthcare Drug Manufacturers Specialty & Generic
Neurocrine Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 21.4% from fiscal 2024.
- Revenue
- +41.2%
- EPS
- −3.67%
- Free cash flow
- +79.0%
Quarter to September 2026, against a year earlier
Follow NBIX
Alert me
Neurocrine Biosciences, Inc. (NBIX) Net income
Neurocrine Biosciences, Inc.'s net income for fiscal 2025 was $478.6M, up 40.2% from $341.3M in fiscal 2024. Over the twelve months to 30 September 2026 it was $702.5M. Over the past ten years it has ranged from −$142.5M (fiscal 2017) to $478.6M (fiscal 2025) — the current reading is the highest in ten years. Net income has risen for 4 consecutive fiscal years. Neurocrine Biosciences, Inc. ranks 6th of 84 Drug Manufacturers Specialty & Generic companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $478.6M | 40.23% |
| FY2024 | $341.3M | 36.68% |
| FY2023 | $249.7M | 61.62% |
| FY2022 | $154.5M | 72.43% |
| FY2021 | $89.6M | (78.00%) |
| FY2020 | $407.3M | 1,000.81% |
| FY2019 | $37.0M | 75.36% |
| FY2018 | $21.1M | — |
| FY2017 | −$142.5M | — |
| FY2016 | −$141.1M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $206.5M | 43.01% |
| Jun 2026 | $144.4M | (27.03%) |
| Mar 2026 | $197.9M | 28.76% |
| Dec 2025 | $153.7M | (26.63%) |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| HLN Haleon PLC Sponsored ADR compare | $3.1B |
| ZTS Zoetis Inc. compare | $2.6B |
| UTHR United Therapeutics Corporation compare | $1.2B |
| NBIX Neurocrine Biosciences, Inc. | $702.5M |
| RDY Dr. Reddy's Laboratories Ltd compare | $273.0M |
| KNSA Kiniksa Pharmaceuticals International, plc compare | $109.6M |
| ALKS Alkermes plc compare | −$351.0K |
| ELAN Elanco Animal Health Incorporated compare | −$199.0M |
| VTRS Viatris Inc. compare | −$607.8M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on NBIX
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement